Prognostic value of test(S) for O 6 -methylguanine-DNA methyltransferase (MGMT) promoter methylation for predicting overall survival in people with glioblastoma treated with temozolomide

Alexandra McAleenan*, Amy Howell, Ashleigh Kernohan, Claire L. Faulkner, Sarah Dawson, Christopher Wragg, Sarah Jefferies, Sebastian Brandner, Luke Vale, Julian P.T. Higgins, Kathreena M. Kurian

*Corresponding author for this work

Research output: Contribution to journalArticle (Academic Journal)peer-review

45 Downloads (Pure)

Search results